Menu Back to Patient-Engagement-throughout-the-Full-Spectrum-of-Drug-Development-An-Interactive-Workshop-for-Life-Science-Companies-and-Patient-Groups

Program Committee

  • Carl  Chiang
    Carl Chiang Director, Clinical Development Zinfandel Pharmaceuticals, United States
  • Marcia K. Horn, JD
    Marcia K. Horn, JD President and Chief Executive Officer International Cancer Advocacy Network (ICAN), United States
  • Lawrence  Liberti, MS, RPh, RAC
    Lawrence Liberti, MS, RPh, RAC Executive Director Centre For Innovation In Regulatory Science (CIRS), United States
  • Elizabeth  Lincoln, MA
    Elizabeth Lincoln, MA Global Director of Engagement DIA, United States
  • Peter  Loupos, MS
    Peter Loupos, MS Senior Director, Partners in Patient Health Sanofi US, United States
  • Prasun  Subedi, PhD, MS
    Prasun Subedi, PhD, MS Associate Director Pfizer Inc, United States
  • FDA Speaker  Invited
    FDA Speaker Invited United States
  • Suzanne  Schrandt
    Suzanne Schrandt Deputy Director of Patient Engagement PCORI, United States
  • Lona  Vincent, MPH
    Lona Vincent, MPH Senior Associate Director Michael J. Fox Foundation For Parkinson's Research, United States
Load More